| HOME >> BIOLOGY >> TECHNOLOGY |
License, manufacturing access fees and
other assets 58,947 59,416
Total assets $761,239 $623,839
Liabilities and stockholders' equity
Current liabilities:
Accounts payable $14,696 $13,586
Accrued salaries and employee benefits 23,055 16,723
Other accrued expenses 8,683 3,320
Income tax payable 732 14,075
Deferred income tax - short term 103 -
Deferred revenue 1,623 921
Total current liabilities 48,892 48,625
Non-current income tax payable 4,766 -
Deferred income tax - long term 360 -
Deferred revenue 3,167 3,667
Deferred rent 40 128
Deferred compensation plan liabilities 1,755 1,211
Commitments and contingencies
Stockholders' equity:
Preferred stock, $.0001 par value per share,
20,000,000 shares authorized,
none issued and outstanding - -
Common stock, $.0001 par value per share;
200,000,000 shares authorized, 53,718,400
and 52,233,656 shares issued and
outstanding at September 30, 2007 and
December 31, 2006, respectively 5 5
Additional paid-in capital 400,883 334,184
Accumulated other comprehensive income (loss) 581 (5)
Retained earnings
'/>"/>
| SOURCE Gen-Probe Incorporated Copyright©2007 PR Newswire. All rights reserved |